Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)

Name: Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)
Creator: Wenchao Wang; Qingwang Liu; Huamin Liang; The First Hospital of Jiaxing; Zhenquan Hu; Hefei Institutes of Physical Science; Tingting Lu; Xixiang Li; Fengming Zou; Ruixiang Xia; Qingsong Liu; First Affiliated Hospital of Anhui Medical University; Wenliang Wang; Aoli Wang; Jiangyan Cao
Published: 2022-10-29T00:00:00+08:00

科学数据银行2022-10-31 更新2026-04-23 收录

激酶抑制剂开发

慢性髓性白血病

数据链接：

https://www.scidb.cn/detail?dataSetId=a713c0e0633a48dd923ddcc07b468615 数据链接链接失效反馈

官方服务：

资源简介：

ABL mutations inhibitory activity in BAF3 cellsModels of ABL kinase wt and mutantsAntiproliferation of CHMFL-48 in CML cell lines In vivo anti-tumour efficacy

提供机构：

Wenchao Wang; Qingwang Liu; Huamin Liang; The First Hospital of Jiaxing; Zhenquan Hu; Hefei Institutes of Physical Science; Tingting Lu; Xixiang Li; Fengming Zou; Ruixiang Xia; Qingsong Liu; First Affiliated Hospital of Anhui Medical University; Wenliang Wang; Aoli Wang; Jiangyan Cao

创建时间：

2022-10-29